Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124316743 | 12431674 | 3 | F | 2012 | 20160801 | 20160603 | 20160812 | EXP | US-009507513-1605USA014718 | MERCK | 0.00 | M | Y | 181.41000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124316743 | 12431674 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 40 MG, QD | 19558 | 40 | MG | TABLET | QD | ||||||
| 124316743 | 12431674 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 80 MG, BID | U | 0 | 80 | MG | TABLET | BID | |||||
| 124316743 | 12431674 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | TABLET | ||||||||||
| 124316743 | 12431674 | 4 | C | IBUPROFEN. | IBUPROFEN | 1 | 6 TO 9 200 MG PILLS DAILY | U | 0 | ||||||||||
| 124316743 | 12431674 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 900 MG, QD | U | 0 | 900 | MG | QD | ||||||
| 124316743 | 12431674 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 1800MG, QD | U | 0 | QD | |||||||||
| 124316743 | 12431674 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 4 - 300 MG CAPSULES DAILY, FREQUENCY UNKNOWN | U | 0 | |||||||||
| 124316743 | 12431674 | 8 | C | NEURONTIN | GABAPENTIN | 1 | 300 MG, QID | U | 0 | 300 | MG | QID | |||||||
| 124316743 | 12431674 | 9 | C | AMITRIPTYLINE HYDROCHLORIDE. | AMITRIPTYLINE HYDROCHLORIDE | 1 | Oral | 1-2 10 MG PILLS HS | U | 0 | QD | ||||||||
| 124316743 | 12431674 | 10 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, TID | U | 0 | 150 | MG | TID | ||||||
| 124316743 | 12431674 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG, QD, FORMULATION PILL | U | 19558 | 40 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124316743 | 12431674 | 1 | Hypertension |
| 124316743 | 12431674 | 2 | Cardiac failure congestive |
| 124316743 | 12431674 | 3 | Oedema |
| 124316743 | 12431674 | 4 | Neuropathy peripheral |
| 124316743 | 12431674 | 5 | Neuropathy peripheral |
| 124316743 | 12431674 | 8 | Neuropathy peripheral |
| 124316743 | 12431674 | 9 | Neuralgia |
| 124316743 | 12431674 | 10 | Neuropathy peripheral |
| 124316743 | 12431674 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124316743 | 12431674 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124316743 | 12431674 | Electric shock | |
| 124316743 | 12431674 | Fall | |
| 124316743 | 12431674 | Mobility decreased | |
| 124316743 | 12431674 | Peripheral venous disease | |
| 124316743 | 12431674 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124316743 | 12431674 | 1 | 2011 | 0 | ||
| 124316743 | 12431674 | 5 | 2003 | 0 |